AIT Bioscience Presents at Delaware Valley Drug Metabolism Discussion Group
Jennifer Vance Shares Tiered Approach to
On Wednesday, January 17th, AIT Bioscience’s Technical Business Manager, Jennifer Vance was an invited speaker at the Delaware Valley Drug Metabolism Discussion Group in Langhorne, PA.
Jennifer presented on the evolution of a tiered approach to method development highlighting previous insights from the Global Bioanalytical Consortium working group and the European Bioanalytical Forum on the topic and proceeding to AIT Biosciences’ approach to tiered method development. She concluded with case studies of method successes and a discussion of ongoing challenges. View her complete presentation to learn more about AIT Biosciences’ fit-for-purpose approach to bioanalysis.
AIT Bioscience is committed to partnering with our sponsors to find the right solutions to their bioanalytical needs that fit their budget, timeline and regulatory needs. We welcome you to read our previous blog posts related to this topic titled AIT Bioscience Offers New Screening Level Assay and What Level of Bioanalytical Method Validation is Right for My Early Stage Drug Development Study? or contact us to have a conversation about your specific needs.